Celcuity (CELC) Amortization of Deferred Charges (2021 - 2025)
Celcuity (CELC) posted Amortization of Deferred Charges of $1.3 million for Q4 2025, up 63.37% on a QoQ basis from $778000.0 in Q3 2025, and up 130.67% year-over-year from $551000.0 in Q4 2024.
Celcuity (CELC) Amortization of Deferred Charges (2021 - 2025) Analysis & Trends
Celcuity's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- Quarterly Amortization of Deferred Charges rose 130.67% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 135.69% YoY) and the FY2025 annual result came in at $3.1 million, up 135.69% from the prior year.
- Amortization of Deferred Charges was $1.3 million for Q4 2025 at Celcuity, up from $778000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.3 million in Q4 2025 and bottomed at $57004.0 in Q1 2023.
- A 5-year average of $293986.6 and a median of $99828.5 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2023 — Amortization of Deferred Charges plunged 42.81% — and 2024, when it jumped 763.46%.
- Celcuity's Amortization of Deferred Charges stood at $94460.0 in 2021, then climbed by 18.12% to $111573.0 in 2022, then slumped by 42.81% to $63813.0 in 2023, then soared by 763.46% to $551000.0 in 2024, then surged by 130.67% to $1.3 million in 2025.
- Business Quant data shows CELC's Amortization of Deferred Charges at $1.3 million in Q4 2025, $778000.0 in Q3 2025, and $537000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 778,000.00 |
| Sep 30, 2025 | 778,000.00 |
| Jun 30, 2025 | 537,000.00 |
| Jun 30, 2025 | 537,000.00 |
| Mar 31, 2025 | 551,000.00 |
| Mar 31, 2025 | 551,000.00 |
| Dec 31, 2024 | 551,000.00 |
| Dec 31, 2024 | 551,000.00 |
| Sep 30, 2024 | 478,000.00 |
| Sep 30, 2024 | 478,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 63,813.00 |
| Dec 31, 2023 | 63,813.00 |
| Sep 30, 2023 | 61,721.00 |
| Sep 30, 2023 | 61,721.00 |